Share

November 08, 2016; 87 (19) NeuroImages

Optical coherence tomography in an optic tract lesion

Retinal nerve fiber layer changes

Alexandra J. Lloyd-Smith, Kannan Narayana, Floyd Warren, Laura J. Balcer, Steven L. Galetta, Janet C. Rucker
First published November 7, 2016, DOI: https://doi.org/10.1212/WNL.0000000000003310
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
526

Share

Article Information

vol. 87 no. 19 2063-2064
DOI: 
https://doi.org/10.1212/WNL.0000000000003310
PubMed: 
27821564
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published November 7, 2016.
Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Alexandra J. Lloyd-Smith, MD, MSc,
    2. Kannan Narayana, MD,
    3. Floyd Warren, MD,
    4. Laura J. Balcer, MD, MSCE,
    5. Steven L. Galetta, MD and
    6. Janet C. Rucker, MD
  1. Alexandra J. Lloyd-Smith, MD, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Kannan Narayana, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Floyd Warren, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Laura J. Balcer, MD, MSCE,
    5. Scientific Advisory Boards:

    1. Biogen

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Biogen, consulting

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Biogen Idec, Novartis, Vaccinex, Questcor, Acorda

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Steven L. Galetta, MD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Biogen and Genzyme

    Editorial Boards:

    1. (1) Neurology, Editorial Board; (2) Journal of Neuro-ophthalmology, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Genzyme Biogen

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Janet C. Rucker, MD
    7. Scientific Advisory Boards:

    1. NIH vestibular migraine data safety monitoring board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. British Journal of Ophthalmology, Section editor - neuro- ophthalmology, 2008-2009, no financial compensation Journal of Neuro-Ophthalmology, Section editor and editorial board member, 2014-present, no financial compensation

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (A.J.L.-S., K.N., F.W., L.J.B., S.L.G., J.C.R.), Population Health (L.J.B.), and Ophthalmology (F.W., L.J.B., S.L.G.), New York University School of Medicine, NY.
  1. Correspondence to Dr. Rucker: Janet.rucker{at}nyumc.org
View Full Text

Article usage

Article usage: November 2016 to May 2022

AbstractFullPdfSource
Nov 2016795558149Highwire
Dec 20161142322Highwire
Jan 2017381111Highwire
Feb 201719618Highwire
Mar 201716920Highwire
Apr 20171345Highwire
May 20171332Highwire
Jun 20171803Highwire
Jul 20171077Highwire
Aug 20171355Highwire
Sep 20171104Highwire
Oct 201781012Highwire
Nov 2017838Highwire
Nov 2017143pmc
Dec 20171132Highwire
Jan 20180192Highwire
Feb 20182154Highwire
Mar 20180162Highwire
Apr 20180103Highwire
Apr 2018022pmc
May 20180191Highwire
Jun 20180121Highwire
Jun 2018199pmc
Jul 20180100Highwire
Aug 2018091Highwire
Aug 2018233pmc
Sep 20180162Highwire
Oct 201804917Highwire
Nov 20180202Highwire
Dec 20180277Highwire
Jan 20192177Highwire
Feb 2019091Highwire
Mar 20190195Highwire
Apr 20190113Highwire
May 2019062Highwire
Jun 2019291Highwire
Jul 20190710Highwire
Aug 20190127Highwire
Sep 20190101Highwire
Oct 20191183Highwire
Nov 2019186Highwire
Dec 2019080Highwire
Jan 2020092Highwire
Feb 2020072Highwire
Mar 20200105Highwire
Apr 20200165Highwire
May 20201106Highwire
Jun 20201151Highwire
Jul 2020289Highwire
Aug 20201184Highwire
Sep 20200110Highwire
Oct 20200176Highwire
Nov 20200137Highwire
Dec 20200283Highwire
Jan 2021185Highwire
Feb 2021140Highwire
Mar 20212135Highwire
Apr 202121910Highwire
May 20212182Highwire
Jun 2021481Highwire
Jul 202142312Highwire
Aug 20211112Highwire
Sep 2021186Highwire
Oct 202113618Highwire
Nov 202111218Highwire
Dec 20210162Highwire
Jan 2022065Highwire
Feb 20222206Highwire
Mar 20220134Highwire
Apr 20221131Highwire
May 20221216Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me